• AHA 2014 Interview: Christopher P. Cannon, MD

    Ron Waksman, MD, interviews Christopher P. Cannon, MD, on IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details